# OnCo record cd52 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/cd52/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "cd52" ;
  schema:name "CD52"@en ;
  schema:description "CD52 is a small protein on nearly all lymphocytes and the target of alemtuzumab, a profoundly immunosuppressive antibody once used in CLL and now mostly in transplant conditioning, T-cell leukaemia and multiple sclerosis."@en ;
  schema:url <https://onco.cc/targets/cd52/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/CD52>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1804>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000169442>, <https://www.uniprot.org/uniprotkb/P31358/entry>, <https://www.ncbi.nlm.nih.gov/gene/1043> ;
  owl:sameAs <http://www.wikidata.org/entity/Q21108353> ;
  schema:citation <https://doi.org/10.1200/JCO.2007.12.9098>, <https://doi.org/10.1038/ng.3415> ;
  onco:tag "gap-fill" ;
  schema:alternateName "CD52" ;
  onco:targetClass "surface-antigen" ;
  onco:firstDescribed "1991"^^xsd:gYear ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/allogeneic-hsct/> ;
  onco:drugs <https://onco.cc/drugs/alemtuzumab/>, <https://onco.cc/drugs/allo-647/> ;
  onco:companies <https://onco.cc/companies/sanofi/> ;
  onco:terms <https://onco.cc/terms/adcc/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-hillmen-j-clin-oncol/> .